Scribe Therapeutics

Description

Engineers CRISPR-based therapeutics by modifying natural CRISPR systems, with treatments focused on cardiometabolic disease and collaborations extending the approach to other therapeutic areas.

Scribe Therapeutics is located in the Silicon Valley ecosystem.

Related

• Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Mammoth BiosciencesDevelops in vivo gene-editing therapeutics, engineers CRISPR-Cas systems and editing strategies, and provides CRISPR-based detection…
• Verve TherapeuticsSingle-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.
• ProfluentBuilds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other protein design…
• Science CorporationDevelops medical and brain-computer interface technologies to help restore vision, cognition, and mobility for patients with debilitating…
• Merck Cambridge Discovery ($MRK)Develops medicines and vaccines through research, clinical trials, and publications, focusing on diseases including cancer, infectious,…
• Intellia Therapeutics ($NTLA)Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited…
• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• Sangamo Therapeutics ($SGMO)Develops genomic medicines using zinc finger technology for patients with severe diseases where current treatments may offer mainly symptom…
• Karyopharm Therapeutics ($KPTI)Develops and investigates oral nuclear export inhibitor cancer therapies for patients with cancer, especially in disease areas with high…
• Xaira TherapeuticsBuilds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation…